The BiaB advantages over traditional methods of RNA manufacturing, include high throughput of high-quality pharmaceutical ...

The two companies have been working together since 2017, and, in 2021, they agreed to collaborate on NM26, a bispecific ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...

Evidence has been growing to suggest that tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, poses risks to the developing fetus by impacting brain development. Now a new ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

Altasciences, a trusted drug development research partner for over 30 years, continues its commitment to providing world-class bioanalytical services. This core business supports both preclinical and ...

The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

including but not limited to that clinical and preclinical drug development involves a lengthy and expensive process with uncertain timelines and outcomes, results of prior preclinical studies and ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...